HomeCompareNVYTF vs FCPT

NVYTF vs FCPT: Dividend Comparison 2026

NVYTF yields 416.67% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVYTF wins by $15446.80M in total portfolio value
10 years
NVYTF
NVYTF
● Live price
416.67%
Share price
$0.48
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15446.85M
Annual income
$10,492,957,272.45
Full NVYTF calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — NVYTF vs FCPT

📍 NVYTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVYTFFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVYTF + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NVYTF pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVYTF
Annual income on $10K today (after 15% tax)
$35,416.67/yr
After 10yr DRIP, annual income (after tax)
$8,919,013,681.58/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, NVYTF beats the other by $8,919,008,772.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVYTF + FCPT for your $10,000?

NVYTF: 50%FCPT: 50%
100% FCPT50/50100% NVYTF
Portfolio after 10yr
$7723.45M
Annual income
$5,246,481,523.86/yr
Blended yield
67.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

NVYTF
No analyst data
Altman Z
-0.6
Piotroski
3/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVYTF buys
0
FCPT buys
0
No recent congressional trades found for NVYTF or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVYTFFCPT
Forward yield416.67%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$15446.85M$49.1K
Annual income after 10y$10,492,957,272.45$5,775.28
Total dividends collected$14996.03M$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: NVYTF vs FCPT ($10,000, DRIP)

YearNVYTF PortfolioNVYTF Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$52,367$41,666.67$11,401$700.92+$41.0KNVYTF
2$259,952$203,920.04$13,064$864.84+$246.9KNVYTF
3$1,224,201$946,051.97$15,051$1,072.48+$1.21MNVYTF
4$5,473,698$4,163,802.84$17,442$1,337.22+$5.46MNVYTF
5$23,256,265$17,399,408.07$20,340$1,677.08+$23.24MNVYTF
6$93,973,351$69,089,147.58$23,880$2,116.57+$93.95MNVYTF
7$361,461,534$260,910,048.59$28,241$2,689.36+$361.43MNVYTF
8$1,324,680,829$937,916,987.81$33,660$3,442.07+$1324.65MNVYTF
9$4,629,809,751$3,212,401,263.77$40,456$4,439.95+$4629.77MNVYTF
10$15,446,853,706$10,492,957,272.45$49,063$5,775.28+$15446.80MNVYTF

NVYTF vs FCPT: Complete Analysis 2026

NVYTFStock

Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. It serves hospitals and corporates. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.

Full NVYTF Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this NVYTF vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVYTF vs SCHDNVYTF vs JEPINVYTF vs ONVYTF vs KONVYTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.